STOCK TITAN
  1. Home
  2. Financials
  3. ADXN
  4. EPS (Diluted)

Addex Therapeutics (ADXN) EPS by Year

ADXN NASDAQ

Addex Therapeutics Ltd lost $0.08 per diluted share in fiscal year 2025. This represents a decrease of 197.9% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Addex Therapeutics Ltd has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.08
YoY -197.9%
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ADXN EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-F
EPS (Diluted)-$0.08-197.9%$0.08n/m-$0.17-$0.50-$0.49n/m-$0.54n/m-$0.58N/AN/A

ADXN EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ2'256-KQ1'256-KQ4'246-KQ2'246-KQ1'246-KQ4'2320-FQ2'236-KQ1'236-KQ4'2220-FQ2'226-KQ1'226-K
EPS (Diluted)N/A-$0.03-117.4%N/AN/A$0.14n/mN/AN/A-$0.04N/AN/A-$0.20n/mN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Addex Therapeutics Ltd financials

Frequently Asked Questions

Addex Therapeutics Ltd lost $0.08 per diluted share in fiscal year 2025.

Addex Therapeutics Ltd (ADXN) diluted earnings per share fell by 197.9% year over year, from $0.08 to -$0.08 in fiscal year 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Addex Therapeutics Ltd (ADXN) reported on that line in every period on record.